Vir Biotechnology, Inc. (VIR)
1 Item 5.02 filing since 2026-10-28 · roles: Director. Nasdaq. Biological Products, (No Diagnostic Substances). State: CA.
| Score | Filed | Event | Role | Person | Seat | Summary |
|---|---|---|---|---|---|---|
| 0 | 2026-10-28 | Board election | Director | subscribers | — | Vir Biotechnology, Inc. (VIR): director Suzanne Topalian, M.D. elected to the board |
Executive changes at other companies: all filings · CEO · CFO · How Item 5.02 works